Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db/db mice

Endocrinology

Volumn 154, Issue 1, 2013, Pages 159-171

  DeMarco, Vincent G ^a,b   Ford, David A ^d   Henriksen, Erik J ^e   Aroor, Annayya R ^a   Johnson, Megan S ^a   Habibi, Javad ^a   Ma, Lixin ^a,c   Yang, Ming ^a,c   Albert, Carolyn J ^d   Lally, John W ^d   Ford, Caleb A ^d   Prasannarong, Mujalin ^e   Hayden, Melvin R ^a   Whaley Connell, Adam T ^a,c   Sowers, James R ^a,b,c  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CITRATE SYNTHASE; FATTY ACID; GLUCOSE; INSULIN; LIPID; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DIET RESTRICTION; DISEASE COURSE; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE ENDSYSTOLIC PRESSURE; HEART VENTRICLE REMODELING; HEART WEIGHT; HOMEOSTASIS; LIPID COMPOSITION; LIPID STORAGE; LIPIDOMICS; MALE; MITOCHONDRION; MOUSE; MYOCARDIUM LIPID LEVEL; NITROSATIVE STRESS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TELEMETRY; TIBIA; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD PRESSURE; CERAMIDES; FATTY ACIDS; MALE; MICE; MYOCARDIUM; OBESITY; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES; REACTIVE OXYGEN SPECIES;

EID: 84871679755     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1835     Document Type: Article

References (60)

1. Santos JL, Salemi VM, Picard MH, Mady C, Coelho OR 2011 Subclinical regional left ventricular dysfunction in obese patients with and without hypertension or hypertrophy. Obesity (Silver Spring) 19:1296-1303
2. Van Putte-Katier N, Rooman RP, Haas L, Verhulst SL, Desager KN, Ramet J, Suys BE 2008 Early cardiac abnormalities in obese children: importance of obesity per se versus associated cardiovascular risk factors. Pediatr Res 64:205-209
3. Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, Kirchmair R, Bahlman F, Walter D, Curry C, Hanley A, Isner JM, Losordo DW 2005 Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 111:2073-2085 (Pubitemid 40577902)
4. Kannel WB, Wilson PW, Zhang TJ 1991 The epidemiology of impaired glucose tolerance and hypertension. Am Heart J 121:1268-1273
5. Lurbe E, Torro I, Aguilar F, Alvarez J, Alcon J, Pascual JM, Redon J 2008 Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension 51:635-641 (Pubitemid 351301514)
6. Seo HS, Kang TS, Park S, Choi EY, Ko YG, Choi D, Ha J, Rim SJ, Chung N 2006 Non-dippers are associated with adverse cardiac remodeling and dysfunction (R1). Int J Cardiol 112:171-177 (Pubitemid 44353794)
7. Ivanovic BA, Tadic MV, Celic VP 8 September 2011 To dip or not to dip? The unique relationship between different blood pressure patterns and cardiac function and structure. J Hum Hypertens 10.1038/jhh.2011.83
8. Bosma M, Kersten S, Hesselink MK, Schrauwen P 2012 Re-evaluating lipotoxic triggers in skeletal muscle: relating intramyocellular lipid metabolism to insulin sensitivity. Prog Lipid Res 51:36-49
9. Lionetti L, Mollica MP, Lombardi A, Cavaliere G, Gifuni G, Barletta A 2009 From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Nutr Metab Cardiovasc Dis 19:146-152
10. Zhang Y, Ren J 2011 Role of cardiac steatosis and lipotoxicity in obesity cardiomyopathy. Hypertension 57:148-150
11. Lopaschuk GD, Folmes CD, Stanley WC 2007 Cardiac energy metabolism in obesity. Circ Res 101:335-347 (Pubitemid 47267702)
12. Luiken JJ, Arumugam Y, Dyck DJ, Bell RC, Pelsers MM, Turcotte LP, Tandon NN, Glatz JF, Bonen A 2001 Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 276:40567-40573
13. Carley AN, Severson DL 2005 Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 1734:112-126 (Pubitemid 40724778)
14. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ 2008 Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 52:1793-1799
15. Christoffersen C, Bollano E, Lindegaard ML, Bartels ED, Goetze JP, Andersen CB, Nielsen LB 2003 Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 144:3483-3490 (Pubitemid 36904426)
16. Hummel KP, Dickie MM, Coleman DL 1966 Diabetes, a new mutation in the mouse. Science 153:1127-1128
17. Coleman DL 1983 Lessons from studies with genetic forms of diabetes in the mouse. Metabolism 32:162-164 (Pubitemid 13077669)
18. da Costa Goncalves AC, Tank J, Diedrich A, Hilzendeger A, Plehm R, Bader M, Luft FC, Jordan J, Gross V 2009 Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction. Hypertension 53:387-392
19. Su W, Guo Z, Randall DC, Cassis L, Brown DR, Gong MC 2008 Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice. Am J Physiol Heart Circ Physiol 295:H1634-H1641
20. Zhang H, Morgan B, Potter BJ, Ma L, Dellsperger KC, Ungvari Z, Zhang C 2010 Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress. Am J Physiol Heart Circ Physiol 299:H985-H994
21. Zhou X, Ma L, Habibi J, Whaley-Connell A, Hayden MR, Tilmon RD, Brown AN, Kim JA, Demarco VG, Sowers JR 2009 Nebivolol improves diastolic dysfunction and myocardial tissue remodeling through reductions in oxidative stress in the Zucker Obese rat. Hypertension 55:880-888
22. Johnson MS, DeMarco VG, Heesch CM, Whaley-Connell AT, Schneider RI, Rehmer NT, Tilmon RD, Ferrario CM, Sowers JR 2011 Sex differences in baroreflex sensitivity, heart rate variability, and end organ damage in the TGR(mRen2)27 rat. Am J Physiol Heart Circ Physiol 301:H1540-H1550
23. DeMarco VG, Johnson MS, Ma L, Pulakat L, Mugerfeld I, Hayden MR, Garro M, Knight W, Britton SL, Koch LG, Sowers JR 2012 Overweight female rats selectively bred for low aerobic capacity exhibit increased myocardial fibrosis and diastolic dysfunction. Am J Physiol Heart Circ Physiol 302:H1667-H1682
24. Whaley-Connell A, Govindarajan G, Habibi J, Hayden MR, Cooper SA, Wei Y, Ma L, Qazi M, Link D, Karuparthi PR, Stump C, Ferrario CM, Sowers JR 2007 Angiotensin-II mediated oxidative stress promotes myocardial tissue remodeling in the transgenic TG (mRen2) 27 Ren2 rat. Am J Physiol Endocrinol Metab 293:E355-E363 (Pubitemid 47105951)
25. DeMarco VG, Habibi J, Whaley-Connell AT, Schneider RI, Heller RL, Bosanquet JP, Hayden MR, Delcour K, Cooper SA, Andresen BT, Sowers JR, Dellsperger KC 2008 Oxidative Stress Contributes to Pulmonary Hypertension in the Transgenic (mRen2) 27 Ren2 Rat. Am J Physiol Heart Circ Physiol 294:H2659-H2668
26. Bligh EG, Dyer WJ 1959 A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
27. Bowden JA, Albert CJ, Barnaby OS, Ford DA 2011 Analysis of cholesteryl esters and diacylglycerols using lithiated adducts and electrospray ionization-tandem mass spectrometry. Anal Biochem 417:202-210
28. Han X, Gross RW 2005 Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev 24:367-412 (Pubitemid 40665798)
29. Han X, Gross RW 2001 Quantitative analysis and molecular species fingerprinting of triacylglyceride molecular species directly from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry. Anal Biochem 295:88-100 (Pubitemid 32721744)
30. Zhang L, Ussher JR, Oka T, Cadete VJ, Wagg C, Lopaschuk GD 2011 Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation. Cardiovasc Res 89:148-156
31. Semeniuk LM, Kryski AJ, Severson DL 2002 Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am J Physiol Heart Circ Physiol 283:H976-H982
32. Vanden Bergh A, Flameng W, Herijgers P 2006 Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions. Eur J Heart Fail 8:777-783 (Pubitemid 44781425)
33. Soylu A, Duzenli MA, Yazici M, Ozdemir K, Tokac M, Gok H 2009 The effect of nondipping blood pressure patterns on cardiac structural changes and left ventricular diastolic functions in normotensives. Echocardiography 26:378-387
34. Senador D, Kanakamedala K, Irigoyen MC, Morris M, Elased KM 2009 Cardiovascular and autonomic phenotype of db/db diabetic mice. Exp Physiol 94:648-658
35. Boudina S, Abel ED 2010 Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11:31-39
36. Ren J, Pulakat L, Whaley-Connell A, Sowers JR 2010 Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med 88:993-1001
37. Bugger H, Abel ED 2010 Mitochondria in the diabetic heart. Cardiovasc Res 88:229-240
38. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED 2005 Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112:2686-2695 (Pubitemid 41532606)
39. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, Abel ED 2007 Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56:2457-2466 (Pubitemid 47523253)
40. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, Abel ED 2005 Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146:5341-5349 (Pubitemid 41653047)
41. Aasum E, Hafstad AD, Severson DL, Larsen TS 2003 Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52:434-441 (Pubitemid 36173200)
42. Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE 2005 Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 96:225-233 (Pubitemid 40209370)
43. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE 2001 A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 107:813-822 (Pubitemid 32274034)
44. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, Yang E, Farrell L, Fox CS, O'Donnell CJ, Carr SA, Vasan RS, Florez JC, Clish CB, Wang TJ, Gerszten RE 2011 Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121:1402-1411
45. Young ME, McNulty P, Taegtmeyer H 2002 Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms. Circulation 105:1861-1870 (Pubitemid 34408899)
46. Bowling N, Walsh RA, Song G, Estridge T, Sandusky GE, Fouts RL, Mintze K, Pickard T, Roden R, Bristow MR, Sabbah HN, Mizrahi JL, Gromo G, King GL, Vlahos CJ 1999 Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation 99:384-391 (Pubitemid 29051264)
47. Hahn HS, Marreez Y, Odley A, Sterbling A, Yussman MG, Hilty KC, Bodi I, Liggett SB, Schwartz A, Dorn 2nd GW 2003 Protein kinase Cα negatively regulates systolic and diastolic function in pathological hypertrophy. Circ Res 93:1111-1119 (Pubitemid 37485043)
48. Abel ED 2011 A newtwist in the function of the cardiac lipid droplet. Nat Med 17:1045-1046
49. O'Donnell JM, Zampino M, Alpert NM, Fasano MJ, Geenen DL, Lewandowski ED 2006 Accelerated triacylglycerol turnover kinetics in hearts of diabetic rats include evidence for compartmented lipid storage. Am J Physiol Endocrinol Metab 290:E448-E455 (Pubitemid 43671690)
50. Harmancey R, Wilson CR, Wright NR, Taegtmeyer H 2010 Western diet changes cardiac acyl-CoA composition in obese rats: a potential role for hepatic lipogenesis. J Lipid Res 51:1380-1393
51. Dowhan W, Bogdanov M, Mileykovskaya E 2008 Functional roles of lipids in membranes. In: Vance DE, Vance JE, eds. Biochemistry of lipids, lipoproteins and membranes. 5th ed. Amsterdam: Elsevier; 1-37
52. Park TS, Hu Y, Noh HL, Drosatos K, Okajima K, Buchanan J, Tuinei J, Homma S, Jiang XC, Abel ED, Goldberg IJ 2008 Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res 49:2101-2112
53. Summers SA 2006 Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45:42-72 (Pubitemid 43170804)
54. Zhang C, Xu X, Potter BJ, Wang W, Kuo L, Michael L, Bagby GJ, Chilian WM 2006 TNF-α contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 26:475-480
55. Torre-Villalvazo I, Gonzalez F, Aguilar-Salinas CA, Tovar AR, Torres N 2009 Dietary soy protein reduces cardiac lipid accumulation and the ceramide concentration in high-fat diet-fed rats and ob/ob mice. J Nutr 139:2237-2243
56. Son NH, Park TS, Yamashita H, Yokoyama M, Huggins LA, Okajima K, Homma S, Szabolcs MJ, Huang LS, Goldberg IJ 2007 Cardiomyocyte expression of PPARγ leads to cardiac dysfunction in mice. J Clin Invest 117:2791-2801 (Pubitemid 47529610)
57. Samad F, Hester KD, Yang G, Hannun YA, Bielawski J 2006 Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55:2579-2587 (Pubitemid 44871159)
58. Lee SY, Kim JR, Hu Y, Khan R, Kim SJ, Bharadwaj KG, Davidson MM, Choi CS, Shin KO, Lee YM, Park WJ, Park IS, Jiang XC, Goldberg IJ, Park TS 2012 Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction. J Biol Chem 287:18429-18439
59. Birse RT, Bodmer R 2011 Lipotoxicity and cardiac dysfunction in mammals and Drosophila. Crit Rev Biochem Mol Biol 46:376-385
60. Fu S, Yang L, Li P, Hofmann O, Dicker L, Hide W, Lin X, Watkins SM, Ivanov AR, Hotamisligil GS 2011 Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473:528-531